Employee Stories
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company
Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.
Luye Pharma Announces 2025 Half-Year Results
- New Product Sales Up 32%, International Strategy Upgraded - Shanghai, August 28, 2025 -- Luye Pharma Group (2186.HK) today announced its 2025 half-year results and latest developments. During the reporting period, its revenue was about ...
August 28,2025
All Patients Enrolled for the Phase III Clinical Trial of Luye Pharma’s Ruoxinlin® for Treating Generalized Anxiety Disorder
Shanghai, August 18, 2025 –- Luye Pharma Group announced that all patients have been enrolled for a Phase 3 clinical trial of its Ruoxinlin® (Toludesvenlafaxine Hydrochloride Sustained-Release Tablets) designated as a Class 1 ...
August 18,2025
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company